Search

Filters
Clear All
  • 13
  • 19
  • 97

Phase

  • 8
  • 6
  • 23
  • 4
  • 25
  • 1
  • 61
  • 128
  • 16

Found 129 will-simon trials

A listing of will-simon medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

N
Nawal Kassem
18 years - 100 years
All genders
What is the purpose of this study?The purpose of this study to understand how patients cope with a hereditary cancer diagnosis, and what factors affect, either positively or negatively, the patient’s ability to cope with their diagnosis.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients …
A
Alexia Torke
18 years - 100 years
All genders
This study investigates the impact of informational support versus spiritual care on patients with cancer. Cancer patients often face challenges in coping with their condition and making treatment decisions. Religion and spirituality can play significant roles in their experience. Therefore, this study will evaluate a spiritual care intervention delivered by …
J
James Croop, MD, PhD
1 years - 21 years
All genders
This study is designed to investigate whether the use of copanlisib is safe, feasible and beneficial to pediatric patients with solid solid tumors or lymphoma that are recurrent or refractory to standard therapy.
J
Justin Sims, MD
18 years - 100 years
All genders
Phase 3
Interventional
What is this study about?This study aims to determine the safety, pharmacokinetics (PK) and recommended Phase 3 dose (RP3D) of RYZ101 in Part 1, and the safety, efficacy, and PK of RYZ101 compared with investigator-selected standard of care (SoC) therapy in Part 2 in subjects with inoperable, advanced, well-differentiated, somatostatin …
R
Rita Assi
18 years - 100 years
All genders
What is the purpose of this study?This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical trials throughout the course of their myeloid cancer (acute myeloid leukemia or myelodysplastic syndrome) treatment. This …
H
Huda Salman
18 years - 100 years
All genders
Phase 1
This study investigates the safety of an investigational treatment using special immune cells called CAR-T cells for people with certain B cell cancers. B cell malignancies are cancers that affect a type of white blood cell. The study includes participants whose cancer has returned or not responded to previous treatments. …
M
Malini Surapaneni
18 years - 100 years
All genders
Phase 2
The purpose of this study is to investigate the use of an investigational medication as a maintenance therapy for patients with multiple myeloma after they have undergone an autologous stem cell transplant. Multiple myeloma is a type of cancer that affects plasma cells in the bone marrow. This study aims …
T
Tareq Salous
18 years - 100 years
All genders
Phase 1
This study investigates the safety, side effects, and effectiveness of an investigational medication in treating advanced solid tumors with FGFR3 alterations, including metastatic urothelial cancer. FGFR3 is a gene that, when altered, can contribute to the growth of cancer cells. The purpose of this study is to understand how the …
18 years - 100 years
All genders
The purpose of this study is to find out what effects, good and/or bad, there are to adding the drug ramucirumab (RAM) to the usual chemotherapy regimen.
G
Greg Durm, MD
18 years - 100 years
All genders
Phase 1/2
This study investigates the safety and tolerability of an investigational medication in participants with locally advanced or metastatic solid tumors that have specific KRAS mutations. KRAS mutations are changes in a gene that can affect cell growth and division, leading to cancer. The study includes participants with KRAS G12C, G12D, …
91 - 100 of 129